CJC without DAC 5mg

Product Overview

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), designed to stimulate the pituitary gland to increase growth hormone (GH) secretion. It consists of 29 amino acids with modifications that extend its half-life, allowing for sustained GH release over time. This peptide is widely studied for its potential to enhance tissue growth, repair, metabolism, and overall anabolic effects in research settings.

Mechanism of Action

CJC-1295 binds to GHRH receptors in the pituitary gland, stimulating the release of endogenous growth hormone. The modifications in CJC-1295 increase its stability and half-life by reducing enzymatic degradation and allowing it to bind to albumin in the bloodstream, thus prolonging its effects. The sustained release of GH triggers downstream effects, including increased insulin-like growth factor 1 (IGF-1) production, which mediates many anabolic and regenerative processes.

Research Applications

• Growth Hormone Secretion: Investigated for its ability to elevate and sustain GH levels, useful in studies related to growth disorders and metabolic research.

• Tissue Repair and Regeneration: Explored for its role in promoting cellular repair, muscle growth, and wound healing.

• Metabolic Effects: Research includes its potential impact on fat metabolism, lean body mass enhancement, and anti-aging properties.

• Sleep and Cognitive Function: Some studies suggest GH modulation via CJC-1295 may influence sleep quality and cognitive function.

• Potential Synergistic Use: Often studied in combination with other peptides such as Ipamorelin for synergistic GH release.

Peptide Stacking Considerations

CJC-1295 is frequently stacked with peptides like Ipamorelin, a ghrelin receptor agonist, to optimize growth hormone pulsatile release while minimizing side effects. Such combinations aim to mimic natural GH secretion more closely. Research into stacking should be conducted cautiously, with careful monitoring of dosage and effects. These peptides remain strictly for research purposes only. (aussiepeptides.com)

Legal and Regulatory Status in Australia

In Australia, CJC-1295 is classified as a Schedule 4 prescription-only medicine under the Poisons Standard. It is not approved by the Therapeutic Goods Administration (TGA) for human therapeutic use, and unauthorized possession or use is illegal. CJC-1295 is not listed on the Australian Register of Therapeutic Goods (ARTG). (tga.gov.au, sportintegrity.gov.au)

Product Specifications

• Purity: ≥98%

• Form: Lyophilized powder

• Available Sizes: 2mg and 5mg vials

• Storage: Store at 4°C or below. For extended storage, keep at -18°C. Protect from light and moisture. (australia.pharmalabglobal.com)

Reconstitution and Handling

For research use, reconstitute CJC-1295 powder with bacteriostatic water by gently injecting the diluent down the vial’s side to avoid foam. Swirl gently until fully dissolved. Avoid shaking. Once reconstituted, store refrigerated and use within a few weeks to maintain stability.

Disclaimer

All products provided by A2V Aminos and Peptides are intended solely for laboratory research purposes. They are not intended for human consumption or veterinary use. Handling should be conducted by qualified personnel only. Users are responsible for compliance with applicable laws regarding research chemical usage.

Note: This information is for educational and research purposes only and does not constitute medical advice. Consult a qualified professional before handling research peptides.